Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Cut to “Underweight” at Barclays

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was downgraded by Barclays from an “equal weight” rating to an “underweight” rating in a research note issued on Monday, MarketBeat reports.

Other equities analysts have also issued reports about the company. Weiss Ratings raised Fresenius Medical Care AG & Co. KGaA from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Truist Financial dropped their price target on Fresenius Medical Care AG & Co. KGaA from $25.00 to $24.00 and set a “hold” rating on the stock in a report on Monday, October 12th. Zacks Research downgraded Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a report on Thursday, October 15th. Sanford C. Bernstein increased their price target on Fresenius Medical Care AG & Co. KGaA from $25.50 to $25.80 and gave the company a “market perform” rating in a research report on Thursday, August 6th. Finally, BNP Paribas Exane lowered Fresenius Medical Care AG & Co. KGaA from a “neutral” rating to an “underperform” rating and set a $19.90 price target for the company. in a research report on Tuesday, July 28th. Seven equities research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus target price of $23.42.

Fresenius Medical Care AG & Co. KGaA Trading Down 0.1%

NYSE FMS opened at $23.39 on Monday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.69 and a current ratio of 0.99. Fresenius Medical Care AG & Co. KGaA has a one year low of $20.02 and a one year high of $26.42. The company has a 50-day simple moving average of $22.33 and a 200-day simple moving average of $22.90. The firm has a market capitalization of $12.45 billion, a PE ratio of 13.52, a price-to-earnings-growth ratio of 5.50 and a beta of 0.78.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last issued its earnings results on Tuesday, November 3rd. The company reported $0.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.01). Fresenius Medical Care AG & Co. KGaA had a return on equity of 9.08% and a net margin of 4.23%. The business had revenue of $5.59 billion during the quarter, compared to the consensus estimate of $5.52 billion. On average, equities analysts forecast that Fresenius Medical Care AG & Co. KGaA will post 2.23 earnings per share for the current year.

Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA

A number of large investors have recently made changes to their positions in the company. Russell Investments Group Ltd. lifted its position in shares of Fresenius Medical Care AG & Co. KGaA by 67.3% in the 3rd quarter. Russell Investments Group Ltd. now owns 22,959 shares of the company’s stock valued at $514,000 after acquiring an additional 9,233 shares in the last quarter. Fifth Third Bancorp boosted its stake in Fresenius Medical Care AG & Co. KGaA by 39.6% in the 3rd quarter. Fifth Third Bancorp now owns 25,653 shares of the company’s stock worth $574,000 after purchasing an additional 7,278 shares during the period. Ritholtz Wealth Management grew its position in Fresenius Medical Care AG & Co. KGaA by 5.2% during the 3rd quarter. Ritholtz Wealth Management now owns 135,135 shares of the company’s stock worth $3,024,000 after purchasing an additional 6,732 shares in the last quarter. Commonwealth Equity Services LLC purchased a new position in Fresenius Medical Care AG & Co. KGaA during the 3rd quarter worth approximately $278,000. Finally, Pzena Investment Management LLC grew its position in Fresenius Medical Care AG & Co. KGaA by 10.8% during the 3rd quarter. Pzena Investment Management LLC now owns 16,617,575 shares of the company’s stock worth $371,901,000 after purchasing an additional 1,625,494 shares in the last quarter. Institutional investors and hedge funds own 8.37% of the company’s stock.

About Fresenius Medical Care AG & Co. KGaA